WHO implementation tool for pre-exposure prophylaxis of HIV infection: provider module for oral and long-acting PrEP

This 2024 update of the provider module of the WHO Implementation tool for pre-exposure prophylaxis of HIV infection replaces the 2017 clinical module. 

The module integrates clinical service delivery guidance for all 3 WHO recommended PrEP products: oral PrEP; the dapivirine vaginal ring; and long acting injectable cabotegravir. It provides practical support and important considerations for the safe and effective PrEP provision by a range of providers, including physicians, nurses, clinical officers, community health workers, pharmacists and lay and peer providers, in either clinical or community settings.

Additional information to the following link: WHO implementation tool for pre-exposure prophylaxis of HIV infection: provider module for oral and long-acting PrEP